UNDERWRITING AGREEMENT 11,115,165 Common Shares AURINIA PHARMACEUTICALS INC. (incorporated under the Business Corporations Act (Alberta))Underwriting Agreement • December 10th, 2019 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Aurinia Pharmaceuticals Inc., a company incorporated under the Business Corporations Act (Alberta) (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom Jefferies LLC (“Jefferies”) and SVB Leerink LLC (“SVB Leerink”) are acting as the representatives (the “Representatives”), an aggregate of 11,115,165 common shares (each, a “Firm Share”), no par value, of the Company (the “Common Shares”). The Company also proposes to grant to the Underwriters an option to purchase up to 1,667,274 additional Common Shares (the “Option Shares” and, together with the Firm Shares, the “Shares”).
